Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jillna Claus
A Single Autologous Stem Cell Transplant (ASCT) Followed by Two Years of Post-Transplant Therapy in Older Recently Diagnosed Multiple Myeloma (MM) Patients. Safety and Response Results From the Prospective Phase II Trial (NCT01849783)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Single Versus Tandem Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma Patients and Role of Second Salvage Transplant: A Single Center Prospective Phase II Study
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
High-Dose Therapy and Autologous Stem Cell Transplant in Older Adults With Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Maintenance Therapy With Low Dose Thalidomide, Dexamethasone and Clarithromycin (BLT-D) Following Autologous Transplant (ASCT) for Multiple Myeloma (MM)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Acute Cognitive Impairment in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplant
Cancer
Cancer Research
Oncology
Impact of Tandem Autologous Stem Cell Transplantation and Response to Transplant in the Outcome of Multiple Myeloma
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology
Autologous Stem Cell Transplant (ASCT) for AIDS-related Lymphoma (ARL)
Infectious Agents and Cancer
Cancer Research
Epidemiology
Oncology
Infectious Diseases
Development and Implementation of Plerixafor Plus G-CSF Mobilization Algorithm for Autologous Stem Cell Transplant (ASCT) in Multiple Myeloma (MM) Patients Treated at Memorial Sloan-Kettering Cancer Center (MSKCC)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Evaluation of High-Dose Melphalan Toxicity by Age in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Autologous Stem Cell Transplant in Multiple Myeloma: Excellent Safety and Efficacy Possible in a Non University Hospital of Developing Country
Journal of Hematology & Thromboembolic Diseases
